Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Medical Countermeasures Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic FeverGlobal Biodefense StaffJune 5, 2025
Tekmira to Provide TKM-Ebola-Guinea for Clinical Studies in W. Africa Featured News December 23, 2014 …
Phase I Clinical Trial Unit for Infectious Disease Therapeutics Contracts + Grants December 18, 2014 …